$10.03 (-0.99%)

Volume: 2.257M

Closed: Dec 02, 2022

Hollow Logo Score: 2.523

Lpath Inc Stock Forecast

$10.03 (-0.99%)

Volume: 2.257M

Closed: Dec 02, 2022

Score Hollow Logo 2.523

Lpath Inc Stock News NASDAQ:APEN

Apollo Endosurgery up 17% after CFO adds shares

07:15pm, Wednesday, 02'nd Mar 2022 Seeking Alpha
Apollo Endosurgery <> jumps after CFO Jeffrey G Read more
Apollo Endosurgery press release (APEN): Q4 GAAP EPS of -$0.27 misses by $0.09.Revenue of $16.2M (+26.0% Y/Y) in-line. Read more
Apollo Endosurgery Inc (APEN) shares closed this week 22.6% lower than it did at the end of last week. The stock is currently down 32.7% year-to-date, up 45.4% over the past 12 months, and down 63.7% over the past five years. This week, the Dow Jones Industrial Average fell 2.4%, and the S&P 500 fell 2.8%. Trading Activity Shares traded as high as $7.52 and as low as $5.63 this week.Trading volume this week was 2.7% higher than the 10-day average and 44.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.5. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index this week, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average this week, beats it on a 1-year basis, and lags it on a 5-year basis The company share price lags the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -494.2% The company's stock price performance over the past 12 months beats the peer average by 169.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc. Read more
Shares of Apollo Endosurgery, Inc. (NASDAQ:APEN) have earned a consensus recommendation of Buy from the six research firms that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year target price among brokers that have issued a report on the stock in the last [] Read more
$35 million funded at close to refinance existing debt, extend maturity and lower interest expenseAdditional borrowing capacity provides minimally dilutive growth capital and strategic flexibilityA Read more
(PR-inside.com) $35 million funded at close to refinance existing debt, extend maturity and lower interest expenseAdditional borrowing capacity provides minimally dilutive growth capital and strategic flexibilityAUSTIN, TX / ACCESSWIRE / December 21, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has entered into a debt financing agreement with an affiliate of Innovatus Capital Partners, LLC ("Innovatus") to provide Apollo with up to $100 million in term loan financing. "We are pleased to partner with a long-term strategic investor such as Innovatus in this transaction," said Chas .. Read more
During the last session, Apollo Endosurgery Inc. (NASDAQ:APEN)s traded shares were 0.8 million, with the beta value of the company hitting 2.21. At the end of the trading day, the stocks price was $8.32, reflecting an intraday gain of 4.00% or $0.32. The 52-week high for the APEN share is $10.39, that puts it down We Just Learned Something New! After Apollo Endosurgery Inc. (NASDAQ: APEN)s 1.59% Gain This Week Read More » Read more

Apollo Endosurgery, Inc. (NASDAQ:APEN) Short Interest Update

06:40am, Wednesday, 15'th Dec 2021 ETF Daily News
Apollo Endosurgery, Inc. (NASDAQ:APEN) was the target of a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 602,300 shares, an increase of 99.8% from the November 15th total of 301,500 shares. Currently, 3.5% of the shares of the company are sold short. Based on [] The post Apollo Endosurgery, Inc. (NASDAQ:APEN) Short Interest Update appeared first on ETF Daily News . Read more
This Laparoscopic Adjustable Gastric Band market research analysis is a critical technique for informing marketing tasks such as determining the needs of target customers. This market research report also covers the business environment, as well as competitive dynamics and requirements. Read more
ShockWave Medical (NASDAQ:SWAV) and Apollo Endosurgery (NASDAQ:APEN) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, dividends, analyst recommendations, earnings and profitability. Institutional & Insider Ownership 91.4% of ShockWave Medical shares are held by institutional investors. Comparatively, 64.7% [] Read more
Apollo Endosurgery, Inc. (NASDAQ:APEN) was the target of a significant decline in short interest during the month of November. As of November 15th, there was short interest totalling 301,500 shares, a decline of 34.3% from the October 31st total of 458,900 shares. Based on an average daily volume of 220,600 shares, the days-to-cover ratio is [] The post Apollo Endosurgery, Inc. (NASDAQ:APEN) Sees Significant Decline in Short Interest appeared first on ETF Daily News . Read more
Apollo Endosurgery, Inc. (NASDAQ:APEN) was the recipient of a large decline in short interest during the month of November. As of November 15th, there was short interest totalling 301,500 shares, a decline of 34.3% from the October 31st total of 458,900 shares. Currently, 1.8% of the companys shares are sold short. Based on an average [] Read more
Geode Capital Management LLC raised its position in shares of Apollo Endosurgery, Inc. (NASDAQ:APEN) by 22.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 119,737 shares of the biotechnology company’s stock after purchasing an additional 22,131 shares during the […] Read more

Hot Stocks To Watch:

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE